Golden
Radiomedix

Radiomedix

A biotechnology company developing targeted radiopharmaceuticals for diagnosing, monitoring, and treating cancer.

Radiomedix is a biotechnology company developing targeted radiopharmaceuticals for diagnosing, monitoring, and treating cancer that is headquartered in Houston, Texas and was founded in 2006 by Dr. Ebrahim S. Delpassand.

Timeline

2006

Radiomedix was founded.

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date

RadioMedix received $2.0 M SBIR Phase II Contract award from NCI NIH for the targeted alpha-emitter therapy of neuroendocrine cancers.

RadioMedix Inc.

Web

RadioMedix Receives $1.4 Million Second Tranche Investment from Texas Emerging Technology Fund

RadioMedix Inc.

Web

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row